Zobrazeno 1 - 10
of 175
pro vyhledávání: ''
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose The objective of this study was to evaluate the safety and efficacy of immune checkpoint inhibitor (ICI) plus anlotinib as third-line treatment in extensive-stage small cell lung cancer (ES-SCLC). Methods A total of 120 patients with ES-SCLC
Autor:
H Safaei, C Mannion, Basim E S Dawoud, C Murphy, U Khan, O Krishnan, L Alderson, J Parmar, S Milne
Publikováno v:
Oral and Maxillofacial Surgery
Introduction The SARS-CoV-2 pandemic forced many governments to impose nation-wide lockdowns. Government legislation forced limited travel on the population with restrictions on the normal way of life to limit spread of the SARS-CoV-2 virus. The aim
Autor:
Alexandre Ferreira, Mathieu Thaunat, Bertrand Sonnery-Cottet, Sylvain Guy, Benjamin Freychet, Thais Dutra Vieira, Alessandro Carrozzo
Publikováno v:
Knee Surgery, Sports Traumatology, Arthroscopy
Purpose The purpose of this study was to determine whether direct arthroscopic control of femoral buttons can prevent improper deployment and soft tissue interposition in anterior cruciate ligament (ACL) reconstruction. Methods A retrospective analys
Publikováno v:
Journal of Neurology
Introduction The diagnosis of psychogenic nonepileptic seizures (PNES) is a common clinical dilemma. We sought to assess the diagnostic value of four ictal signs commonly used in differentiating PNES from epileptic seizures (ES). Methods We retrospec
Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis
Autor:
Adam Cuker, Lincy Geevarghese, Savita Nandal, Lincy S. Lal, Lisa Le, Pallavi Patwardhan, Adrienne Landsteiner
Publikováno v:
Annals of Hematology
Immune thrombocytopenia (ITP) may occur in isolation (primary) or in association with a predisposing condition (secondary ITP [sITP]). Eltrombopag is a well-studied treatment for primary ITP, but evidence is scarce for sITP. We evaluated real-world u
Autor:
Enrico Vidal, Zaccaria Ricci, Fabio Paglialonga, Stuart L. Goldstein, Licia Peruzzi, Claudio Ronco, Mario Giordano, Nicola Laforgia
Publikováno v:
Pediatric Nephrology (Berlin, Germany)
Background The most severely ill neonates and infants with AKI who need kidney replacement therapy have had to rely upon peritoneal dialysis, or adaptations of veno-venous continuous kidney replacement therapy (CKRT) devices for adults. Data from the
Autor:
Alessandro Pontis, Angelos Daniilidis, Felice Sorrentino, Stefano Angioni, Maurizio Nicola D'Alterio, Raffaele Tinelli, Luigi Nappi, Michele Peiretti
Publikováno v:
Archives of Gynecology and Obstetrics
PurposeTo evaluate whether laparoscopic treatment with a diode laser is feasible, safe, and effective in symptomatic patients affected by deep endometriosis (DE).MethodsThis retrospective study was performed using medical record data. The surgical re
Autor:
P. S. Satheeshkumar, Minu P. Mohan
Publikováno v:
Clinical Oral Investigations
Objectives To evaluate the association and risk factors of healthcare-associated infection (HAI) and burden of illness among chemotherapy-induced ulcerative mucositis (UM) patients. Methods For this research, US National Inpatient Sample database 201
Autor:
Ulrich Germing, Rainer Haas, Judith Strapatsas, Michael Lauseker, Jennifer Kaivers, Corinna Strupp, Elena Calina Barbulescu, Kathrin Nachtkamp, Martina Rudelius, Barbara Hildebrandt
Publikováno v:
Annals of Hematology
Thrombocytopenia at diagnosis and platelet drop within the first 6 months have an adverse effect on prognosis of MDS patients. We therefore were interested in the association and impact on prognosis of morphologic findings of megakaryocytes and plate
Autor:
Mariateresa Falco, Pietro Strisciuglio, Ilaria De Maggio, Fortunato Lonardo, Daniela Melis, Gabriella Maria Squeo, Giuseppe Merla, Gerarda Cappuccio, Gioacchino Scarano, Carmen Rosano, Maria Siano, Claudia Mandato, Carmelo Piscopo, Paolo Fontana, Francesca Di Candia, P. Paglia, Daniele De Brasi, Matteo Della Monica
Publikováno v:
European Journal of Pediatrics
Kabuki syndrome (KS) is a well-recognized disorder characterized by postnatal growth deficiency, dysmorphic facial features, skeletal anomalies, and intellectual disability. The syndrome is caused by KMT2D gene mutations or less frequently KDM6A gene